SCHEMBL13062203

SCHEMBL13062203

CCOCCn1c2ccccc2c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ KDM4E B2RXH2 3/20 0.53
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ PTGER4 P35408 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.47
▸ FABP3 P05413 1/20 0.46
▸ FABP4 P15090 1/20 0.46
▸ FABP5 Q01469 1/20 0.46
▸ SIGMAR1 Q99720 2/20 0.45
▸ PPARG P37231 1/20 0.45
▸ PPARD Q03181 1/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ GPR3 P46089 1/20 0.45
▸ PGR P06401 1/20 0.45
▸ RORA P35398 1/20 0.45
▸ RORC P51449 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17993963 0.96 MEN1 (0.70) MEN1KMT2AKDM4ECYP1A2CYP2C19
SCHEMBL13223738 0.96 MEN1 (0.70) MEN1KMT2AKDM4ECYP1A2CYP2C19
SCHEMBL17788576 0.89 MEN1 (0.60) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL19563138 0.87 MEN1 (0.51) MEN1KMT2AKDM4EALDH1A1PTGER4
SCHEMBL14117041 0.86 MAOA (0.64) MEN1KMT2AKDM4ECYP1A2CYP2C19
SCHEMBL20872249 0.85 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1PTGER4
SCHEMBL25132549 0.84 MEN1 (0.62) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL20855922 0.84 MEN1 (0.55) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL30272659 0.84 MEN1 (0.55) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL13553021 0.83 MEN1 (0.49) MEN1KMT2AKDM4ECYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 — — US disclosed
US-20170003589-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME TAKOMA TECHNOLOGY CO., LTD (KR) 2017-01-05 — — US disclosed
US-20170003589-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME TAKOMA TECHNOLOGY CO., LTD (KR) 2017-01-05 — — US disclosed
US-20170003589-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME TAKOMA TECHNOLOGY CO., LTD (KR) 2017-01-05 — — US disclosed
EP-3057961-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME Takoma Technology Co., Ltd. (KR) 2016-08-24 — — EP disclosed
WO-2015080503-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME TAKOMA TECHNOLOGY CO., LTD. (KR) 2015-06-04 — — WO disclosed
WO-2015080503-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME TAKOMA TECHNOLOGY CO., LTD. (KR) 2015-06-04 — — WO disclosed
US-20100324259-A1 HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS INTEZYNE TECHNOLOGIES, INC. (US) 2010-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 MEN1 2488/4885KMT2A 3943/4885KDM4E 2604/4885
US-20170003589-A1 PHOTOINITIATOR AND PHOTOSENSITIVE COMPOSITION INCLUDING THE SAME LCP1, ALAD, PITHD1 MEN1 3921/4885KMT2A 425/4885KDM4E 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback